摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,12-dodecamethylene bis[(4-ethoxycarbonylmethyl)thiazol-5-yl] | 321915-89-3

中文名称
——
中文别名
——
英文名称
1,12-dodecamethylene bis[(4-ethoxycarbonylmethyl)thiazol-5-yl]
英文别名
dodecamethylenebis[5-(4-ethoxycarbonyl-methyl)thiazole];Ethyl 2-[5-[12-[4-(2-ethoxy-2-oxoethyl)-1,3-thiazol-5-yl]dodecyl]-1,3-thiazol-4-yl]acetate
1,12-dodecamethylene bis[(4-ethoxycarbonylmethyl)thiazol-5-yl]化学式
CAS
321915-89-3
化学式
C26H40N2O4S2
mdl
——
分子量
508.747
InChiKey
LHHAWGRCDCRTQI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    112-114 °C
  • 沸点:
    599.9±45.0 °C(Predicted)
  • 密度:
    1.125±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    7.7
  • 重原子数:
    34
  • 可旋转键数:
    21
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    135
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    1,12-dodecamethylene bis[(4-ethoxycarbonylmethyl)thiazol-5-yl]溴甲苯乙醇 为溶剂, 反应 48.0h, 以60%的产率得到dodecamethylenebis[5-(1-methyl-4-ethoxycarbonylethyl)-thiazolium] dibromide
    参考文献:
    名称:
    Mono- and Bis-Thiazolium Salts Have Potent Antimalarial Activity
    摘要:
    Three new series comprising 24 novel cationic choline analogues and consisting of mono- or his (N or C-5-duplicated) thiazolium salts have been synthesized. Bis-thiazolium salts showed potent antimalarial activity (much superior to monothiazoliums). Among them, bis-thiazolium salts 12 and 13 exhibited IC50 values of 2.25 nM and 0.65 nM, respectively, against P. falciparum in vitro. These compounds also demonstrated good in vivo activity (ED50 <= 0.22 mg/kg), and low toxicity in mice infected by Plasmodium vinckei.
    DOI:
    10.1021/jm0492608
  • 作为产物:
    描述:
    1,12-二溴十二烷 、 sodium hydride 作用下, 以 四氢呋喃四氯化碳丙酮 为溶剂, 反应 122.84h, 生成 1,12-dodecamethylene bis[(4-ethoxycarbonylmethyl)thiazol-5-yl]
    参考文献:
    名称:
    Mono- and Bis-Thiazolium Salts Have Potent Antimalarial Activity
    摘要:
    Three new series comprising 24 novel cationic choline analogues and consisting of mono- or his (N or C-5-duplicated) thiazolium salts have been synthesized. Bis-thiazolium salts showed potent antimalarial activity (much superior to monothiazoliums). Among them, bis-thiazolium salts 12 and 13 exhibited IC50 values of 2.25 nM and 0.65 nM, respectively, against P. falciparum in vitro. These compounds also demonstrated good in vivo activity (ED50 <= 0.22 mg/kg), and low toxicity in mice infected by Plasmodium vinckei.
    DOI:
    10.1021/jm0492608
点击查看最新优质反应信息

文献信息

  • Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
    申请人:Vial Henri
    公开号:US06972343B1
    公开(公告)日:2005-12-06
    The invention concerns drug precursors with antimalarial effect, characterised in that it consists in quaternary bis-ammonium salts of general formula (I) wherein A and A′, identical or different, are respectively either a group A1 and A′1 of formula (1) wherein n=2 to 4; R′1 is hydrogen, C1-C5 alkyl, optionally substituted by an aryl, a hydroxy, an alkoxy, wherein the alkyl comprises 1 to 5 C, or aryloxy and W is halogen or a nucleofuge group; or a group A2 which represents formyl-CHO, or acetyl-COCH3. B and B′, identical or different, represent respectively either the group B1 and B′1, if A and A′ respectively represent A1, A′1, B1, B′1 representing a group R1 which has the same definition as R′1 above, but cannot be a hydrogen atom; or respectively the groups B2 and B′2, if A and A′ represent A2, B2 or B′2 being the group R1 as defined above, or a group of formula (2) wherein —Ra is RS— or RCO—, wherein R is a C1-C6 alkyl, substituted if required, a phenyl or benzyl, wherein the phenyl is substituted if required, the latter being optionally substituted; R2 is hydrogen, C1-C5 alkyl, or a —CH2-COO— (C1-C5)alkyl group; and R3 is hydrogen, C1-C5 alkyl or alkenyl, substituted if required, a phosphate, an alkoxy wherein the alkyl is a C1-C3 alkyl, or aryloxy; or an alkyl (or arylcarbonyloxy; or R2 and R3 form together a cycle with 5 or 6 C; R and R3 can be bound to form a cycle. ± represents: either a single bond when A and A′ represent A1 and A′1: or when A and A′ represent A2, and B2 and B′2 Represent (3) either, when A and A′ are —CHO or —COCH3 and B2 and B′2 are R1, a group of formula (4) or a group of formula (5) wherein (a) represents a bond towards Z and (b) a bond towards the nitrogen atom. Z is a C9-C21 alkyl, if required with insertion of one or several bonds, and/or one or several heteroatoms O and/or S and/or several aromatic cycles, and the pharmaceutically acceptable salts of said compounds. Said precursors and cyclized thiazolium derivatives are useful as antiparasitic medicines in particular antimalarial and antibabesiosis.
    该发明涉及具有抗疟疾作用的药物前体,其特征在于它由通式(I)的季铵双盐组成,其中A和A′,相同或不同,分别是通式(1)的A1和A′1基团,其中n=2至4;R′1是氢,C1-C5烷基,可选地被芳基、羟基、烷氧基(其中烷基包括1至5个碳)、芳氧基取代,W是卤素或亲核离去基;或者是代表甲酰基-CHO或乙酰基-COCH3的A2基团。B和B′,相同或不同,分别代表A和A′分别表示A1、A′1、B1、B′1的情况下的B1和B′1基团,其中B1、B′1代表与上述R′1相同定义的R1基团,但不能是氢原子;或者分别代表A和A′表示A2的情况下的B2和B′2基团,其中B2或B′2是如上定义的R1基团,或者是通式(2)的基团,其中-Ra是RS-或RCO-,其中R是C1-C6烷基,必要时取代,苯基或苄基,其中苯基在必要时取代,后者是可选地取代的;R2是氢、C1-C5烷基,或者是—CH2-COO-(C1-C5)烷基;R3是氢、C1-C5烷基或烯烃基,必要时取代,磷酸酯、烷氧基(其中烷基是C1-C3烷基)或芳氧基;或者是烷基(或芳基羰基氧基;或者R2和R3共同形成一个含有5或6个碳的环;R和R3可以结合形成一个环。±表示:当A和A′表示A1和A′1时,是单键;或者当A和A′表示A2,B2和B′2表示(3)时,当A和A′为—CHO或—COCH3,B2和B′2为R1时,是通式(4)的基团或通式(5)的基团,其中(a)表示朝向Z的键,(b)表示朝向氮原子的键。Z是C9-C21烷基,必要时插入一个或多个键,和/或一个或多个杂原子O和/或S,和/或几个芳香环,以及所述化合物的药学上可接受的盐。所述前体和环化噻唑衍生物作为抗寄生虫药物,特别是抗疟疾和抗巴贝斯病的药物是有用的。
  • Mono- and Bis-Thiazolium Salts Have Potent Antimalarial Activity
    作者:Abdallah Hamzé、Eric Rubi、Pascal Arnal、Michel Boisbrun、Carole Carcel、Xavier Salom-Roig、Marjorie Maynadier、Sharon Wein、Henri Vial、Michèle Calas
    DOI:10.1021/jm0492608
    日期:2005.5.1
    Three new series comprising 24 novel cationic choline analogues and consisting of mono- or his (N or C-5-duplicated) thiazolium salts have been synthesized. Bis-thiazolium salts showed potent antimalarial activity (much superior to monothiazoliums). Among them, bis-thiazolium salts 12 and 13 exhibited IC50 values of 2.25 nM and 0.65 nM, respectively, against P. falciparum in vitro. These compounds also demonstrated good in vivo activity (ED50 <= 0.22 mg/kg), and low toxicity in mice infected by Plasmodium vinckei.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺